IP Library Granted Patent US 8,900,560
Granted Patent B2
US 8,900,560 · App. 13/848,968 · Granted Dec 2, 2014

Amide dendrimer compositions

Inventors: Pradeep K. Dhal (Westford, MA); David J. Harris (Lexington, MA); Stephen Randall Holmes-Farley (Arlington, MA); Chad C. Huval (Somerville, MA); Vitaly Nivorozhkin (Boxborough, MA); Bruce Shutts (Bolton, MA)
Assignee: Genzyme Corporation
A61K31/785
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,900,560
App. No.
13/848,968
Granted
Dec 2, 2014
Kind
B2
Abstract

Amide compounds, amide polymers, compositions including amide compounds and amide polymers may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, amide compounds and amide polymers may include a core derived from an amide polyol and an organic polyacid or ester.

Claims (16)

1. A pharmaceutical composition comprising

a) an amide compound represented by the following Formula V:

wherein

R 3 is independently represented by the following Formula II:

wherein

p, q and r independently represent an integer from 0-2;

R 4 independently represents

wherein

m independently represents an integer from 1-20;

R 5 independently represents a hydrogen radical; a substituted or un-substituted alkyl radical; a substituted or un-substituted aryl radical; or R 5 and a neighboring R 5 together represent a link or links comprising a residue of a crosslinking agent, a substituted or un-substituted alicyclic radical, a substituted or un-substituted aromatic radical, or a substituted or un-substituted heterocyclic radical; or R 5 represents a link with another compound;

b) a crosslinking agent or residue thereof; and

c) a pharmaceutically acceptable excipient.

2. A pharmaceutical composition comprising

a) an amide compound represented by the following Formula VI:

b) a crosslinking agent or residue thereof; and

c) a pharmaceutically acceptable excipient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2014
From: DHAL, PRADEEP K.; HARRIS, DAVID J.; HOLMES-FARLEY, STEPHEN RANDALL; NIVOROZHKIN, VITALY; HUVAL, CHAD C.; SHUTTS, BRUCE
To: GENZYME CORPORATION
Reel/Frame 033991/0948 →
Continuity (3)
Continuation 12311362
Provisional Application 60847905 · Sep 29, 2006
Related Publication 20130251667A1 · Sep 26, 2013